{"slug":"vip-trigeminal","verification":{"valid":true,"entries":2,"head":"b6e5a24ee5dc8519fcd0d9d784ee01c137f292ec65fb77a373695690947d20ef"},"energy":{"passes":2,"tokens_in":11975,"tokens_out":3010,"tokens_total":14985,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"b6e5a24ee5dc8519fcd0d9d784ee01c137f292ec65fb77a373695690947d20ef"},"provenance":[{"ts":"2026-06-29T22:13:48.250Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: Vip for Trigeminal\nSlug: vip-trigeminal\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_focus\",\"condition\":null,\"condition_key\":null,\"primary_peptide\":null,\"peptides_in_scope\":[{\"id\":\"vip\",\"name\":\"VIP\"}],\"drugs_in_scope\":[],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"vip\",\"name\":\"VIP\",\"section_title\":\"Why VIP might help you\",\"layer\":\"immune / autonomic\",\"steps\":[\"**Therefore for you:** If that layer is part of your problem, VIP is discussed because it targets repair (tissue) — not because it masks pain.\"],\"prose\":\"1. **Therefore for you:** If that layer is part of your problem, VIP is discussed because it targets repair (tissue) — not because it masks pain.\"}],\"drug_chains\":[],\"stimulant_chains\":[],\"stack_together\":\"Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\\n- **VIP** → immune / autonomic\",\"section_headings\":[\"What's breaking down\",\"Why VIP might help you\",\"How these fit together\",\"What the evidence actually shows\",\"What scientists say\",\"What people say on Reddit\",\"What people say on X\",\"What we do not know\",\"Safety and limits\"],\"writer_rules\":[\"One ## section per compound in peptide_chains — do not merge into one peptide essay.\",\"Each Why section must use if-then steps from peptide_chains / drug_chains.\",\"weight_s","response":"{\n  \"slug\": \"vip-trigeminal\",\n  \"title\": \"VIP for Trigeminal Issues: Evidence on Repair Pathways\",\n  \"body\": \"## What's breaking down\\n\\nTrigeminal neuralgia and related nerve issues often involve layers of degeneration in the trigeminal nerve and ganglion. One layer is mechanical or vascular compression that can lead to focal demyelination. Another is local inflammation that keeps nerves hyperexcitable. A third layer involves autonomic imbalance because parasympathetic fibers using VIP interact with trigeminal pathways. A fourth possible layer is reduced tissue repair signals after repeated irritation. When breakdown outruns repair at these layers, pain signals persist or amplify. VIP is discussed in research because it participates in immune modulation and autonomic signaling, not because it simply blocks sensation.\\n\\n## Why VIP might help you\\n\\nIf the immune and autonomic layer contributes to your trigeminal symptoms, VIP is studied for its potential role in tissue-level repair signals. Step one: elevated VIP appears in cerebrospinal fluid and blood during active trigeminal neuralgia episodes in people. Step two: VIP acts on VPAC receptors that can dampen certain inflammatory signals from Schwann cells and support neuron survival in lab models of nerve injury. Step three: if autonomic dysregulation or excess inflammation is driving your nerve irritation, this receptor activity might shift the balance toward repair rather than ongoing breakdown. Therefore for you: VIP is discussed because it targets repair (tissue) — not because it masks pain.\\n\\n## How these fit together\\n\\nSingle-compound focus. VIP maps to the immune/autonomic layer listed above. If your profile also includes other degeneration layers such as direct myelin repair or central sensitization, additional compounds would target those separately without overlap in this article.\\n\\n## What the evidence actually shows\\n\\nHuman data: Zhao et al. (2002) measured VIP during trigeminal neuralgia attacks a","tokens_in":11975,"tokens_out":3010,"cost":0,"prev":"genesis","hash":"648b8531eff00cbfcc3159f79ca9b0e53c9a5d5f18387862ab26ff8626386907"},{"ts":"2026-07-17T02:43:28.366Z","model":"owner","action":"voxel_divide","prompt":"","input":"vip-trigeminal","response":"20 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"648b8531eff00cbfcc3159f79ca9b0e53c9a5d5f18387862ab26ff8626386907","hash":"b6e5a24ee5dc8519fcd0d9d784ee01c137f292ec65fb77a373695690947d20ef"}]}